Home>>Infectious Disease>> Parasitic Diseases>>4-Deoxypyridoxine (hydrochloride)

4-Deoxypyridoxine (hydrochloride) (Synonyms: 4-Deoxypyridoxine, DOP, 4-DPD)

Catalog No.GC42369

4-Deoxypyridoxine (4-DPD) is a vitamin B6 antimetabolite with diverse biological activities.

Products are for research use only. Not for human use. We do not sell to patients.

4-Deoxypyridoxine (hydrochloride) Chemical Structure

Cas No.: 148-51-6

Size Price Stock Qty
100mg
$33.00
In stock
250mg
$69.00
In stock
500mg
$114.00
In stock
1g
$211.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

4-Deoxypyridoxine (4-DPD) is a vitamin B6 antimetabolite with diverse biological activities. It inhibits transport of pyridoxine , pyridoxal, and pyridoxamine in and reduces growth of S. carlsbergensis cells. 4-DPD inhibits sphingosine-1-phosphate (S1P) lyase and reduces cyclic stretch-induced apoptosis in alveolar epithelial MLE-12 cells. 4-DPD (5 mg, i.p.) reduces lysyl oxidase activity by 26% and reduces collagen and elastin crosslinking, resulting in limb abnormalities in chick embryos. It decreases latency to first seizure in mice (ED50 = 1 mmol/kg) and increases the occurrence and duration of myoclonic responses in baboons with photosensitive epilepsy. 4-DPD reduces TNF-α and IL-6 production in mice infected with T. spiralis.

Reviews

Review for 4-Deoxypyridoxine (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4-Deoxypyridoxine (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.